![]() |
|
|
MJ Seaton, GA Kyerematen and ES Vesell
Department of Pharmacology, Pennsylvania State University, College of Medicine, Hershey 17033.
A new HPLC assay was adapted for radiometric detection of nicotine metabolites in rat bile. Two glucuronides were identified as the principal biliary metabolites of nicotine. In addition to nicotine glucuronide and 3-hydroxycotinine glucuronide, cotinine was also detected in bile after administration to rats of a single subcutaneous dose of (-)-S-nicotine (0.2 or 1.0 mg/kg) that contained a tracer dose of rac-[pyrrolidine-2'-14C]nicotine (20 microCi). Biliary metabolites accounted for only 3% of the [14C]nicotine dose, but phenobarbital pretreatment (100 mg/kg ip for 3 days) increased the amount of [14C]nicotine-derived radioactivity recovered in bile to 8% and also accelerated rates of biliary excretion of all three nicotine metabolites. Dose-dependency of nicotine metabolism occurred: less nicotine glucuronide was excreted at the low dose than at the high dose.
This article has been cited by other articles:
![]() |
O. Ghosheh and E. M. Hawes Microsomal N-Glucuronidation of Nicotine and Cotinine: Human Hepatic Interindividual, Human Intertissue, and Interspecies Hepatic Variation Drug Metab. Dispos., December 1, 2002; 30(12): 1478 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Caporaso, C. Lerman, J. Audrain, N. R. Boyd, D. Main, H. J. Issaq, B. Utermahlan, R. T. Falk, and P. Shields Nicotine Metabolism and CYP2D6 Phenotype in Smokers Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 261 - 263. [Abstract] [Full Text] |
||||